Comparative Analysis of Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: Surgical Risks and Weight Loss Outcomes

Overview

This retrospective study compared outcomes of Roux-en-Y gastric bypass (GB) and sleeve gastrectomy (SG) in 719 patients over a 2-year follow-up. GB demonstrated significantly greater weight loss but was associated with higher rates of minor complications and longer hospital stays. Both procedures improved metabolic parameters, but GB showed a higher risk of anemia and micronutrient deficiencies.

Background

Obesity affects millions in the US, with morbid obesity increasing despite preventive efforts. Bariatric surgery, including GB and SG, offers effective weight loss and comorbidity resolution, but the optimal procedure remains debated. GB has a longer history with well-documented outcomes, while SG is a newer stand-alone procedure with growing use. Balancing weight loss benefits against surgical risks and long-term complications is critical for patient management.

Data Highlights

Key Findings

• GB patients achieved significantly greater excess body weight loss at 24 months compared to SG patients.
• GB was associated with a higher rate of minor postoperative complications and longer hospital stays.
• Both procedures improved blood pressure and HbA1c, indicating metabolic benefits.
• GB patients showed increased risk of anemia and micronutrient deficiencies, necessitating careful monitoring.
• SG, while newer, demonstrated fewer immediate surgical risks but less weight loss efficacy.
• Creatinine changes suggested differences in lean body mass and renal function impacts between procedures.

Clinical Implications

Clinicians should weigh the superior weight loss benefits of GB against its higher complication rates and risk of anemia when advising patients. SG may be preferable for patients prioritizing lower surgical risk, though with potentially less weight loss. Long-term monitoring for micronutrient deficiencies and renal function is essential regardless of procedure choice.

Conclusion

Roux-en-Y gastric bypass offers greater weight loss but at the cost of increased minor complications and anemia risk compared to sleeve gastrectomy. Individualized patient assessment is crucial to optimize surgical choice and postoperative management.

References

1. American Obesity Statistics 2020 -- Prevalence of Obesity in the US
2. CMS Coverage for Sleeve Gastrectomy 2012 -- Medicare and Medicaid Policies
3. Long-term Outcomes of Gastric Bypass 2015 -- Weight Loss and Comorbidity Resolution
4. RCTs Comparing GB and SG 2014-2018 -- Weight Loss Efficacy
5. Meta-analyses of Bariatric Surgery Outcomes 2016-2019 -- Comparative Effectiveness
6. Michigan Bariatric Surgery Collaborative 2017 -- Complication Grading and Reporting